0001209191-24-001875.txt : 20240118
0001209191-24-001875.hdr.sgml : 20240118
20240118202429
ACCESSION NUMBER: 0001209191-24-001875
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240118
FILED AS OF DATE: 20240118
DATE AS OF CHANGE: 20240118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CALSADA CRISPINA
CENTRAL INDEX KEY: 0001606833
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 24543459
MAIL ADDRESS:
STREET 1: C/O AMBRX, INC.
STREET 2: 10975 N. TORREY PINES RD.
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 4224 CAMPUS POINT COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-18
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001606833
CALSADA CRISPINA
C/O REGULUS THERAPEUTICS
4224 CAMPUS POINT COURT #210
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-01-18
4
S
0
5468
1.1906
D
5782
D
Sale of shares of common stock to cover tax withholding obligations incurred in connection with the vesting of the restricted stock unit award received by the Reporting Person on 1/11/2023.
Christopher Aker, Attorney in Fact
2024-01-18